GB2356402B - Use of radio-labelled antibody to bacterial compounds in the diagnosis of focal infection in humans - Google Patents

Use of radio-labelled antibody to bacterial compounds in the diagnosis of focal infection in humans

Info

Publication number
GB2356402B
GB2356402B GB0017940A GB0017940A GB2356402B GB 2356402 B GB2356402 B GB 2356402B GB 0017940 A GB0017940 A GB 0017940A GB 0017940 A GB0017940 A GB 0017940A GB 2356402 B GB2356402 B GB 2356402B
Authority
GB
United Kingdom
Prior art keywords
humans
diagnosis
radio
labelled antibody
bacterial compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB0017940A
Other versions
GB2356402A (en
GB0017940D0 (en
Inventor
Michael G Morgan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to GB0017940A priority Critical patent/GB2356402B/en
Publication of GB0017940D0 publication Critical patent/GB0017940D0/en
Publication of GB2356402A publication Critical patent/GB2356402A/en
Application granted granted Critical
Publication of GB2356402B publication Critical patent/GB2356402B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/60—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances involving radioactive labelled substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1009—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against material from bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Optics & Photonics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
GB0017940A 2000-07-22 2000-07-22 Use of radio-labelled antibody to bacterial compounds in the diagnosis of focal infection in humans Expired - Fee Related GB2356402B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0017940A GB2356402B (en) 2000-07-22 2000-07-22 Use of radio-labelled antibody to bacterial compounds in the diagnosis of focal infection in humans

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0017940A GB2356402B (en) 2000-07-22 2000-07-22 Use of radio-labelled antibody to bacterial compounds in the diagnosis of focal infection in humans

Publications (3)

Publication Number Publication Date
GB0017940D0 GB0017940D0 (en) 2000-09-13
GB2356402A GB2356402A (en) 2001-05-23
GB2356402B true GB2356402B (en) 2001-10-31

Family

ID=9896095

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0017940A Expired - Fee Related GB2356402B (en) 2000-07-22 2000-07-22 Use of radio-labelled antibody to bacterial compounds in the diagnosis of focal infection in humans

Country Status (1)

Country Link
GB (1) GB2356402B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005524624A (en) * 2001-12-21 2005-08-18 バイオシネクサス インコーポレーテッド Multifunctional monoclonal antibody against peptidoglycan of gram-positive bacteria

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4566769A (en) * 1982-12-29 1986-01-28 Olympus Optical Co., Ltd. Power supply unit for electronic flash
US4888279A (en) * 1984-12-21 1989-12-19 Thomas Jefferson University Novel immunosorbent assays employing antibiotic keying agents
US5177192A (en) * 1987-04-02 1993-01-05 Centocor, Incorporated Method for labeling antibodies with a metal ion
US5328679A (en) * 1988-04-01 1994-07-12 Immunomedics, Inc. Methods for technetium/rhenium labeling of proteins
US5840272A (en) * 1992-06-09 1998-11-24 Perimmune Holdings, Inc. Imaging infectious foci with human IgM 16.88

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4566769A (en) * 1982-12-29 1986-01-28 Olympus Optical Co., Ltd. Power supply unit for electronic flash
US4888279A (en) * 1984-12-21 1989-12-19 Thomas Jefferson University Novel immunosorbent assays employing antibiotic keying agents
US5177192A (en) * 1987-04-02 1993-01-05 Centocor, Incorporated Method for labeling antibodies with a metal ion
US5328679A (en) * 1988-04-01 1994-07-12 Immunomedics, Inc. Methods for technetium/rhenium labeling of proteins
US5840272A (en) * 1992-06-09 1998-11-24 Perimmune Holdings, Inc. Imaging infectious foci with human IgM 16.88

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Arthritis Rheum.; Vol 43 (3), pp 593-598 (2000). Van der Heijden et al. *
Clin Immunol Immunopathol; Vol 71 (3), pp303-308 (1994). Klasen et al. *

Also Published As

Publication number Publication date
GB2356402A (en) 2001-05-23
GB0017940D0 (en) 2000-09-13

Similar Documents

Publication Publication Date Title
LTPA2020001I1 (en) Anti-IL-12 Antibodies, Compositions, Techniques, and Use for the Treatment of Crohn's Pathology
TWI316088B (en) Anti-tnf alpha antibodies and their uses
AU9549001A (en) Antibodies to human IL-1beta
HK1050013A1 (en) ANTIBODIES TO HUMAN IL-1β
IL144578A0 (en) Antibodies specific to kdr and uses thereof
IS6779A (en) Human antibody against LT-beta-R
IL166809A (en) Liquid aqueous formulations comprising human anti-tnf alpha antibodies
IL155092A0 (en) Compounds useful in the treatment of inflammatory diseases
AU8390301A (en) Antibodies to human MCP-1
HUP0302376A3 (en) Anti-tnf antibodies, compositions, methods and uses
MA27126A1 (en) 3'PROMEDICAMENTS OF 2'-DESOXY- β-L-NUCLEOSIDES
HUP0402333A3 (en) Modified anti-tnf alpha antibody
ATE357459T1 (en) ANTIBODIES TO HUMAN IL-12
FR2809312B1 (en) USE OF L. CASEI IN IMMUNOSTIMULATING COMPOSITIONS
ID26300A (en) OBJECTIVE ABSORPTION ONCE USE
GB0007333D0 (en) Novel compounds and their manufacture and use
DE60118910D1 (en) PHOSPHATE CONVERSION PROCESSING AND COMPOSITION
GB2356402B (en) Use of radio-labelled antibody to bacterial compounds in the diagnosis of focal infection in humans
FR2851379B1 (en) CONVERTER IN DIRECT TRANSFER OF ENERGY
NO20031036L (en) Preparations for the diagnosis of extra-pancreatic secretory function
ES1050081Y (en) PERFECTED FEMALE USE URINE COLLECTOR
GB9921046D0 (en) Therapeutic antibody composition & use
FR2818131B1 (en) COSMETIC COMPOSITION COMPRISING HEPARANASE
SE0002629D0 (en) Novel compounds and their use
GB0001116D0 (en) Diagnosis of toxicoinfectious clostridiosis

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20040722